• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素抵抗通过多种机制加剧阿尔茨海默病。

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms.

作者信息

Wei Zenghui, Koya Jagadish, Reznik Sandra E

机构信息

Department of Pharmaceutical Sciences, St. John's University, New York, NY, United States.

Department of Pathology, Albert Einstein College of Medicine, New York, NY, United States.

出版信息

Front Neurosci. 2021 Jul 19;15:687157. doi: 10.3389/fnins.2021.687157. eCollection 2021.

DOI:10.3389/fnins.2021.687157
PMID:34349617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8326507/
Abstract

Alzheimer disease (AD) is a chronic neurodegenerative disease that accounts for 60-70% of dementia and is the sixth leading cause of death in the United States. The pathogenesis of this debilitating disorder is still not completely understood. New insights into the pathogenesis of AD are needed in order to develop novel pharmacologic approaches. In recent years, numerous studies have shown that insulin resistance plays a significant role in the development of AD. Over 80% of patients with AD have type II diabetes (T2DM) or abnormal serum glucose, suggesting that the pathogenic mechanisms of insulin resistance and AD likely overlap. Insulin resistance increases neuroinflammation, which promotes both amyloid β-protein deposition and aberrant tau phosphorylation. By increasing production of reactive oxygen species, insulin resistance triggers amyloid β-protein accumulation. Oxidative stress associated with insulin resistance also dysregulates glycogen synthase kinase 3-β (GSK-3β), which leads to increased tau phosphorylation. Both insulin and amyloid β-protein are metabolized by insulin degrading enzyme (IDE). Defects in this enzyme are the basis for a strong association between T2DM and AD. This review highlights multiple pathogenic mechanisms induced by insulin resistance that are implicated in AD. Several pharmacologic approaches to AD associated with insulin resistance are presented.

摘要

阿尔茨海默病(AD)是一种慢性神经退行性疾病,占痴呆症病例的60 - 70%,是美国第六大死因。这种使人衰弱的疾病的发病机制仍未完全明确。为了开发新的药物治疗方法,需要对AD的发病机制有新的认识。近年来,大量研究表明胰岛素抵抗在AD的发展中起重要作用。超过80%的AD患者患有2型糖尿病(T2DM)或血糖异常,这表明胰岛素抵抗和AD的致病机制可能重叠。胰岛素抵抗会增加神经炎症,进而促进淀粉样β蛋白沉积和异常的tau蛋白磷酸化。胰岛素抵抗通过增加活性氧的产生,触发淀粉样β蛋白的积累。与胰岛素抵抗相关的氧化应激还会使糖原合酶激酶3-β(GSK-3β)失调,导致tau蛋白磷酸化增加。胰岛素和淀粉样β蛋白都由胰岛素降解酶(IDE)代谢。该酶的缺陷是T2DM与AD之间密切关联的基础。本综述重点介绍了胰岛素抵抗诱导的、与AD相关的多种致病机制。还介绍了几种针对与胰岛素抵抗相关的AD的药物治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ea6/8326507/b75d76ffbd74/fnins-15-687157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ea6/8326507/b75d76ffbd74/fnins-15-687157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ea6/8326507/b75d76ffbd74/fnins-15-687157-g001.jpg

相似文献

1
Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms.胰岛素抵抗通过多种机制加剧阿尔茨海默病。
Front Neurosci. 2021 Jul 19;15:687157. doi: 10.3389/fnins.2021.687157. eCollection 2021.
2
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.糖尿病与阿尔茨海默病:糖原合成酶激酶-3β作为潜在联系
Behav Brain Res. 2018 Feb 26;339:57-65. doi: 10.1016/j.bbr.2017.11.015. Epub 2017 Nov 21.
3
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.从紊乱的大脑葡萄糖代谢解码阿尔茨海默病:对诊断和治疗策略的影响。
Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11.
4
Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.饮食诱导的胰岛素抵抗在阿尔茨海默病转基因小鼠模型中促进淀粉样变性。
FASEB J. 2004 May;18(7):902-4. doi: 10.1096/fj.03-0978fje. Epub 2004 Mar 19.
5
The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.星形胶质细胞释放的胰岛素样生长因子结合蛋白3在阿尔茨海默病病理学中的作用。
Mol Brain. 2015 Dec 4;8(1):82. doi: 10.1186/s13041-015-0174-2.
6
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.植物环烯醚萜类化合物在阿尔茨海默病和帕金森病中的治疗潜力:综述。
Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8.
7
Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.胰岛素缺乏促进了在阿尔茨海默病模型中与过度磷酸化 tau 寡聚体共聚集的有毒淀粉样-β42 构象体的形成。
Neurobiol Dis. 2020 Apr;137:104739. doi: 10.1016/j.nbd.2020.104739. Epub 2020 Jan 10.
8
Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity.利拉鲁肽通过调节神经元胰岛素信号和 BACE-1 活性抑制 Tau 过度磷酸化、淀粉样β 聚集。
Int J Mol Sci. 2020 Mar 3;21(5):1725. doi: 10.3390/ijms21051725.
9
Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease.炎症与氧化应激:胰岛素抵抗、肥胖症和阿尔茨海默病之间的分子联系
Mediators Inflamm. 2015;2015:105828. doi: 10.1155/2015/105828. Epub 2015 Nov 26.
10
Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.胰岛素降解酶和中性内肽酶在阿尔茨海默病生物学中的作用:治疗应用中潜在同源物的特性
J Alzheimers Dis. 2015;48(4):891-917. doi: 10.3233/JAD-150379.

引用本文的文献

1
Mechanisms of IGF1R signaling in type 2 diabetes-related neurodegeneration and therapeutic implications of exercise.2型糖尿病相关神经退行性变中IGF1R信号传导机制及运动的治疗意义
Eur J Med Res. 2025 Aug 30;30(1):825. doi: 10.1186/s40001-025-03087-0.
2
Fecal Short-Chain Fatty Acids Vary by Sex and Amyloid Status.粪便短链脂肪酸因性别和淀粉样蛋白状态而异。
medRxiv. 2025 Aug 1:2025.07.31.25332523. doi: 10.1101/2025.07.31.25332523.
3
Ramipril and ketogenic diet response in cognitive dysfunction of insulin-resistant rats.雷米普利与生酮饮食对胰岛素抵抗大鼠认知功能障碍的影响

本文引用的文献

1
Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.更深入地了解肿瘤坏死因子与神经退行性疾病发病机制可推断出新的治疗方法。
J Alzheimers Dis. 2021;79(3):931-948. doi: 10.3233/JAD-201186.
2
Alzheimer's disease drug development pipeline: 2020.2020年阿尔茨海默病药物研发进展
Alzheimers Dement (N Y). 2020 Jul 16;6(1):e12050. doi: 10.1002/trc2.12050. eCollection 2020.
3
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.
Front Pharmacol. 2025 Jul 11;16:1620139. doi: 10.3389/fphar.2025.1620139. eCollection 2025.
4
The Inflammatory Nexus: Unraveling Shared Pathways and Promising Treatments in Alzheimer's Disease and Schizophrenia.炎症关联:揭示阿尔茨海默病和精神分裂症的共同途径及有前景的治疗方法
Int J Mol Sci. 2025 Jun 27;26(13):6237. doi: 10.3390/ijms26136237.
5
Bridging systemic metabolic dysfunction and Alzheimer's disease: the liver interface.连接全身代谢功能障碍与阿尔茨海默病:肝脏的界面
Mol Neurodegener. 2025 May 28;20(1):61. doi: 10.1186/s13024-025-00849-6.
6
Let-7 Family as a Mediator of Exercise on Alzheimer's Disease.Let-7家族作为运动对阿尔茨海默病影响的介导因子
Cell Mol Neurobiol. 2025 May 19;45(1):43. doi: 10.1007/s10571-025-01559-9.
7
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance.高迁移率族蛋白A1(HMGA1)缺乏:tau蛋白病变与胰岛素抵抗之间的致病联系。
EBioMedicine. 2025 May;115:105700. doi: 10.1016/j.ebiom.2025.105700. Epub 2025 Apr 14.
8
Amyloid β1-40 Predicts Long-Term Mortality Rate in Patients With Acute Myocardial Infarction.淀粉样蛋白β1-40可预测急性心肌梗死患者的长期死亡率。
J Am Heart Assoc. 2025 Apr 15;14(8):e035620. doi: 10.1161/JAHA.124.035620. Epub 2025 Apr 3.
9
Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies.3型糖尿病与脑神经元的代谢重编程:病因与治疗策略
Mol Med. 2025 Feb 18;31(1):61. doi: 10.1186/s10020-025-01101-z.
10
Therapeutic Efficacy of the Inositol D-Pinitol as a Multi-Faceted Disease Modifier in the 5×FAD Humanized Mouse Model of Alzheimer's Amyloidosis.肌醇 D-松醇作为多方面疾病修饰剂在 5×FAD 人源化阿尔茨海默病淀粉样变性小鼠模型中的治疗效果。
Nutrients. 2024 Dec 4;16(23):4186. doi: 10.3390/nu16234186.
经鼻给予胰岛素治疗轻度认知障碍和阿尔茨海默病痴呆的安全性、有效性和可行性:一项随机临床试验。
JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.
4
Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.Aβ 寡聚体对神经元 APP 的影响引发了一个恶性循环,导致突触可塑性改变向健康神经元传播。
J Neurosci. 2020 Jul 1;40(27):5161-5176. doi: 10.1523/JNEUROSCI.2501-19.2020. Epub 2020 May 22.
5
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.肿瘤坏死因子(TNF)阻断剂与类风湿关节炎和银屑病患者患阿尔茨海默病的风险降低相关。
PLoS One. 2020 Mar 23;15(3):e0229819. doi: 10.1371/journal.pone.0229819. eCollection 2020.
6
Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity.利拉鲁肽通过调节神经元胰岛素信号和 BACE-1 活性抑制 Tau 过度磷酸化、淀粉样β 聚集。
Int J Mol Sci. 2020 Mar 3;21(5):1725. doi: 10.3390/ijms21051725.
7
Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics.计算机辅助β-分泌酶、γ-分泌酶和抗 tau 抑制剂的药物设计用于发现新型阿尔茨海默病治疗药物。
Int J Mol Sci. 2020 Jan 21;21(3):703. doi: 10.3390/ijms21030703.
8
GSK3β is a key regulator of the ROS-dependent necrotic death induced by the quinone DMNQ.GSK3β 是醌 DMNQ 诱导的 ROS 依赖性坏死死亡的关键调节因子。
Cell Death Dis. 2020 Jan 2;11(1):2. doi: 10.1038/s41419-019-2202-0.
9
Phosphorylation Signaling in APP Processing in Alzheimer's Disease.阿尔茨海默病中 APP 处理的磷酸化信号转导。
Int J Mol Sci. 2019 Dec 27;21(1):209. doi: 10.3390/ijms21010209.
10
Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease.淀粉样β寡聚体靶向阿尔茨海默病中的细胞外和细胞内神经元突触蛋白。
Front Neurol. 2019 Nov 1;10:1140. doi: 10.3389/fneur.2019.01140. eCollection 2019.